# The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex

> **NCT05558969** · NA · COMPLETED · sponsor: **Eskisehir Osmangazi University** · enrollment: 30 (actual)

## Conditions studied

- Magnesium Sulfate
- Pregnancy; Pre-Eclampsia
- Neuromuscular Blockade

## Interventions

- **DRUG:** pregnant women taking magnesium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05558969
- **Lead sponsor:** Eskisehir Osmangazi University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-28
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-05-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05558969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05558969, "The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05558969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*